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Takotsubo cardiomyopathy (TTC) is a transient left ventricular apical, medial or basal 
dysfunction, recovering completely without myocardial injury. It was first clinically described 
in 1991 by Sato et al. Impact of psychological distress and personality factors remains 
unclear. The aim of the study was to assess if the personality trait of neuroticism, can increase 
the vulnerability for TTC.  
Material and methods: 
A systematic literature search was performed in MEDLINE in august 2018, using relevant 
MeSH terms obtained from PubMed. The search was limited to literature in the time period 
2007 – 2018. Study designs included clinical studies, comparative studies, interviews, journal 
articles, randomized control trials, “reviews” and systematic reviews. 206 records were 
identified through database searching. After screening of abstracts, 88 articles remained. 
Selected studies were then assessed for their relevance to the thesis and for scientific quality.  
Results: 
TTC consists predominantly of postmenopausal women. Presenting symptoms are chest pain 
and dyspnea. The majority has an emotional stressor combined with a physical or isolated 
emotional stressor. Anxiety and distress are observed as prominent factors. Though, a 
correlation between personality type D (PTD) or neuroticism with TTC is incomplete 
regarding evidence. Most studies underline acute stressful events as a trigger for TTC, while 
other publications highlight the impact of cumulative stress as more significant.  
Conclusion: 
The current literature did not show significant correlations between TTC, depression, PTD 
and neuroticism. However, anxiety has been proven to be a prominent feature. Studies have 
identified stressful events immediately preceding the acute event. However, some results 
indicate that exposure to repeated stressful events may have a more decisive role in onset of 
TTC. Response to distressing factors depends on personality traits, vulnerability and 





Explanation of concepts and abbreviations  
Takotsubo cardiomyopathy (TTC): A transient left ventricular apical, medial or basal 
dysfunction most often accompanied by apical ballooning and electrocardiographic (ECG) ST 
– elevation or T wave inversions. This abnormality is associated with high levels of 
catecholamines, either administered or endogenously secreted from a tumor or during extreme 
stress.  
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of 
the cardiac muscle itself. Cardiomyopathies are classified according to their predominant 
pathophysiological features (dilated cardiomyopathy; hypertrophic cardiomyopathy, 
restrictive cardiomyopathy or their etiological/pathological factors (cardiomyopathy, 
alcoholic, endocardial fibroelastosis)). 
Acute coronary syndrome (ACS): An episode of myocardial ischemia that generally lasts 
longer than a transient anginal episode that ultimately may lead to myocardial infarction.  
Coronary vasospasm: Spasm of the large- or medium-sized coronary arteries.  
Myocardial stunning: Prolonged dysfunction of the myocardium after a brief episode of 
severe ischemia, with gradual return of contractile activity. 
Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to 
the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the 
coronary arteries (coronary artery disease), to obstruction by a thrombus, or less commonly, 
to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption 
of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle 
(myocardial infarction).    
Myocardial infarction: Necrosis of the myocardial tissue caused by an obstruction of the 
blood supply to the heart.                                                                                                              
Coronary artery disease: Pathological processes of coronary arteries that may derive from a 
congenital abnormality, atherosclerotic, or non-atherosclerotic cause.                            
Hypothalamic-pituitary-adrenal axis: HPA-axis. 
Catecholamine: A general class of ortho-dihydroxy phenylalkylamines derived from 
tyrosine. An overall term for epinephrine and norepinephrine, among other terms.                        




Physiological stress: The unfavorable effect of environmental factors (stressors) on the 
physiological functions of an organism. Prolonged unresolved physiological stress can affect 
homeostasis of the organism and may lead to damaging or pathological conditions.  
Autonomic nervous system: The enteric nervous system; parasympathetic nervous system 
and sympathetic nervous system taken together. The autonomic nervous system regulates the 
internal environment during both peaceful activity and physical or emotional stress. 
Autonomic activity is controlled and integrated by the central nervous system, especially the 
hypothalamus and the solitary nucleus, which receive information relayed from visceral 
afferents. 
Glucocorticoids: A group of corticosteroids that affect carbohydrate metabolism 
(gluconeogenesis, liver glycogen deposition, elevation of blood sugar), inhibit 
adrenocorticotropic hormone secretion, and possess pronounced anti-inflammatory activity. 
They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, 
alteration of the connective tissue response to injury, reduction in the number of circulating 
lymphocytes, and functioning of the central nervous system.  
Personality: Behavior-response patterns that characterize the individual.   
Anxiety: Feeling or emotion of dread, apprehension, and an impending disaster but not 
disabling as with anxiety disorders.  
Personality type D (PTD): Behavior pattern characterized by negative emotionality 
(negative affectivity), an inability to express emotions, and social isolation (social inhibition), 
which has been linked to greater cardiovascular disease and increased mortality.   
Hypochondriasis: Preoccupation with the fear of having, or the idea that one has, a serious 
disease based on the person's misinterpretation of bodily symptoms.  
Neuroticism: A pervasive tendency to experience negative emotional states. Neurotic 
individuals are more likely to experience anxiety, anger, guilt, major depression and respond 
poorly to environmental stress. They may also have difficulty controlling urges and delaying 
gratification. Polymorphisms in the SLC6A4 gene promoter have been identified. This 
concept is a supplementary term under the overall term anxiety disorders.   
  




1 Introduction  
   
“Doctor: “Please tell us what happened before your chest pain started?” 
“Miss X: “Well I was thinking about terrible things that happened when I was young and I 
felt pressure in my heart and the emotions all ran to my chest and I couldn't get the images 
out of my head and my heart couldn't bear it so I felt the terrible pain but I wasn't surprised 
because, with all the emotion, what else was my heart to do? 
"The heart does have emotion, you see…. You don't believe me, do you?”” 
"When I met Miss X (quoted above), I assumed she had misinterpreted the significance of her 
emotions in relation to her cardiac symptoms. However, to some degree, she was correct. 
Whether or not her heart ‘has emotion’ is perhaps down to semantics (does ‘having emotion’ 
require emotion generation or simply sensitivity to emotion?), but medical investigations 
confirmed that her chest pain was the result of Takotsubo cardiomyopathy broken heart 
syndrome’. This is a poorly understood condition where intense emotional or physical stress 
brings about potentially lethal changes to cardiac contractility, changes that are distinctly 
different from those found in a ‘normal’ heart attack. For Miss X, extreme emotion threatened 
to literally ‘break’ her heart."(1) 
 
1.1 History of Takotsubo Cardiomyopathy 
From the early 1990s, Japanese authors described a type of acute, transient and reversible 
cardiomyopathy, similar to ST elevated acute myocardial infarction (AMI) either in clinical 
presentation or electrocardiography (ECG) and cardiac parameters. A peculiarity of the 
syndrome was left ventricular (LV), apical or medium apical segment dyskinesia/akinesia 
during the acute phase, commonly recovering very rapidly. (2) This clinical phenomenon was 
first described in Japan by Sato et al. (1) in 1991 and is probably still an underdiagnosed 
disease. (3) Some other terms used for this condition are stress induced cardiomyopathy, 
broken heart syndrome, apical ballooning and Takotsubo syndrome. Because of its feature, 
the syndrome was given the name Takotsubo cardiomyopathy (TTC) which was recalling the 
shape of a trap used by fishermen to catch octopus. (2) TTC mimics acute coronary 
syndromes (ACS), but in the absence of obstructive coronary artery disease. Emotional 




of TTC. (4, 5) Ghadri et al. (2016) refer to recent studies which have shown a connection 
between TTC and a positive life event, introducing a new term, “happy heart 
syndrome”. (6) This indicates a generalized reaction to stress, independent of positive or 
negative loaded emotions. Despite extensive research, the cause, pathogenesis and 
heterogeneity of clinical features is incompletely understood. Particular emphasis has been 
devoted to the role of the central and autonomic nervous system, and catecholamine surge. (2)  
 
1.2 Laboratory findings 
Apart from the extensive wall motion abnormalities in TTC patients, the cardiac biomarkers 
creatinine kinase (CK) and troponin levels are limitedly elevated, and CK rarely exceeds 
values above 500U/l. Furthermore, as a result of left ventricular wall stretching, plasma 
concentrations of brain natriuretic peptide (BNP) are remarkably elevated in patients with 
TTC compared to ACS patients. (7-12) Although different profiles of cardiac biomarkers are 
evident, no cut-off values for troponin, CK and BNP have yet been defined as useful for 
discrimination of TTC and ACS. (13) On the other hand, circulating micro-RNA has been 
shown to be a potential diagnostic tool in the acute phase to differentiate TTC from STEMI, 
but this laboratory finding is still not accessible for clinical use. (14)  
 
1.3 Triggering events 
In a majority of patients (70-80%) a triggering event can be identified. There are equal 
distributions of emotional and physical stress in 30-40% of the patients. (15, 16) These data 
depend on the precision of clinical history taking, which may vary in large registries. In 
addition, it may also be difficult to differentiate the stressors. (16) Surprisingly, many studies 
have pointed out that in a great amount of cases, sometimes up to one third of the cases, there 
are no known triggering event.  
 
1.4 Diagnosis 
Guidelines for TTC diagnosis have been presented from various sources, with some 
differences in inclusion and exclusion criteria. When immersing the literature concerning our 




most of the prior studies have emphasized that obstructive coronary disease must be excluded. 
In recent years however, new criteria have been suggested where absence of obstructive 
coronary disease is no longer excluded. The possibility that TTC and coronary artery disease 
could coexist is important to remember, as not all patients with TTC have normal arteries. 
(17) Two international expert consensus documents on TTC have been published. They assert 
that TTC is a poorly recognized heart disease where current guidelines are lacking, and 
controversies are present such as nomenclature, different TTC types, role of coronary artery 
disease and cause. The diagnosis of TTC is often challenging, and a wide range of 
heterogeneity patterns and clinical presentation of TTC has been acknowledged. (2)   
Because of variations in literature concerning the Mayo criteria, all modified versions are 
considered. Latest proposed guidelines from EHJ (European Heart Journal) 2018 will be 
presented and reviewed in our discussion. 
 
 
Figure 1: Angiographic image of a Takotsubo cardiomyopathy (TTC) patient with non – 




The increasing number of patients referred to coronary angiography with suspected ACS have 




patients presented with ACS symptoms have been identified as TTC. Its incidence is 
estimated to be 29, 8 per 1,000,000 inhabitants in a global population. (18) The prevalence of 
TTC is predominated by postmenopausal women, regardless of ethnicity. (19)   
 
1.6 Influence of gender and age 
The mean age range of patients with TTC is between 58 and 75 years, and about 90% of the 
cases occur in women. In all studies reported so far, a large discrepancy in prevalence of TTC 
between men and women has been established. (11, 20-34) Explanations regarding this is 
contradictory, and no clear pathophysiological explanation is ascertained. (35) The reason 
why TTC mainly affect postmenopausal women is not fully understood, but it is proposed that 
the lack of the cardio protective effect of oestrogen may play an important role.  
Gender specific prevalence presenting with ACS symptoms is higher in women ranging from 
6 - 9.8%, whereas the prevalence among male patients presented with ACS symptoms is less 
than 0.5%. (36-38) According to case descriptions, men constitute less than 11% of TTC 
cases in Western countries. However, the number of male patients in Asia seems to be higher 
in registry-studies ranging from 13 - 35%. (30, 39, 40) It is currently unclear whether 
underdiagnosis or misdiagnosis may contribute to the lower prevalence of TTC in men. 
Furthermore, in addition to lower prevalence in men, it has been reported that men more often 
experience sudden death in the early phase of TTC. In the case of early death, diagnosis 
cannot be established because of missing documentation of the typical course of this 
syndrome including normal coronary arteries and rapid resolution of the wall abnormality. 
(16) In – hospital mortality has been reported to range from 0 - 8% and is typically reported in 
the 1 - 2% range. (7, 28, 41, 42) In an inpatient - database from the United States which 
included 24.701 TTC patients, risk factors and outcome were analysed. Differences in the 
mortality rate between gender was prominent, were the mortality rate was 2,5 times higher in 
men than in women. (32, 33) Akashi et al. (2015) also points out that mortality in men seems 
to be higher than in women according to several studies, but these reports were based on a 
small sample of patients. (17)       
Younger women seem to be occasionally affected. (11, 20-34) Approximately 10% of patients 




genders may be affected. Furthermore, there are some case reports of younger females with 
TTC in the context of normal pregnancy (43) after miscarriage, and after labour or delivery. 
(44-47) In addition, it is suggested that in the postpartum period women may be at risk of 
developing TTC because of the abrupt depletion of oestrogen levels after expulsion of the 
placenta. Also, in particular after caesarean delivery, TTC may be triggered either by an 
intense emotional and/or physical stress of the simultaneous administration of the 
catecholamines, which are often used to stimulate uterine contraction. (45) 
The youngest known individual affected by TTC was 2 days old and the onset was triggered 
by foetal distress and hypoxemia. (48) Other children developing TTC are those undergoing 
surgery or in the context of morphine withdrawal. (49-53) Overall, the triggering factors, 
presentation, clinical course, ECG and echocardiographic findings are similar in children and 
adults. (50)  
 
1.7 Genetics 
According to the literature reviewed, it seems to be still unknown, if genetics play an 
important role. Pellicia et al. (2017) noted that mechanisms of myocardial protection seem to 
act differently in individuals because of genetic variability in general. (54) Several studies 
analyzing polymorphism potentially involved in the pathogenesis of TTC have demonstrated 
differences in the various subtypes of both adrenoceptors (55) and oestrogen receptors. (56) A 
genetic predisposition to TTC might explain why some develop the disease without preceding 
stressor or are at risk of recurrence. (57) Vriz and colleagues demonstrated an increased 
genotype frequency of a beta-1 adrenergic receptor (β1AR) polymorphism (amino acid 
position 389) in patients with TTC compared to controls, but other researchers could not 
reproduce these findings. (58) Other genetic polymorphisms such as L41Q and L14 were also 
suggested, but so far without significant evidence. (59, 60) Larger genetic studies are 
necessary, the most recent research indicates a genetic vulnerability of adrenergic cell 






1.8 Pathophysiology  
The pathophysiology of TTC is not completely understood. (62)  
Most recent evidence supports the concept of increased catecholamine concentration in the 
acute phase of TTC. This might induce direct myocardial injury and coronary spasm, mostly 
at the microvascular level. Additionally, due to increased cardiac workload which contributes 
to an acute situation of supply-demand mismatch, it may result in post-ischemic stunning. The 
functional counterpart at the LV level would be the typical apical ballooning that persists as a 
result of stunned myocardium, followed by complete functional recovery over relatively short 
time-periods. (54)   
Naegele et al. (2016) has brought additional information to the pathogenesis of TTC. The new 
concept claims that the condition differs markedly from cardiomyopathies as currently 
defined. A common factor in patients with TTC is endothelial dysfunction which is a 
pathological state of the endothelium characterized by an imbalance between vasoconstricting 
and vasodilating factors. The imbalance mentioned above may represent a link between stress 
and myocardial dysfunction in TTC. (63)  
The common feature of primary (no prior medical cause) and secondary (complication due to 
medical illness) TTC cases are the surge of catecholamines and enhanced sympathetic 
activity. This has been central to a better understanding of the syndrome and has through the 
years led to the term “stress cardiomyopathy”. Clinical studies have demonstrated extremely 
high levels of catecholamines in TTC patients. (5) The serum concentrations of epinephrine 
(EPI) and norepinephrine (NE) are significantly higher in these patients compared to patients 
with myocardial infarction (5), and further on they remain elevated. Interestingly, serum half-
life of EPI is almost 3 min (64) if TTC is caused by a stressor that triggered a large, but short 
catecholamine secretion. 24 h later, the plasma EPI concentration should be 480 half-lives 
lower, with tiny concentrations still circulating. The clinical observations support a prolonged 
activation of the sympathetic nervous system, combined with molecular and physiological 
“memory” of the catecholamine storm. (65) 
To explore in detail the pathophysiology of TTC, researchers have obtained information from 
animal models. Ueyama et al. 2002 and 2003, Redfors et al. (2014), Shao et al. (2013) and 
Paur et al. (2012) to mention some, have studied animal reactions to pharmacological and 




findings below are based on experimental studies performed on rats, monkeys and mice.  
Both sexes were included, an exogenous dose of catecholamines were administered, and the 
time frame of observation was 20 min to 10 days. Some studies included intervention, others 
not. These observations have given us directly insight to the initial symptoms of TTC at a 
molecular level, in addition to the ongoing hours and days. 
 
1.9 Time course 
0-60 seconds: 
Plasma levels of catecholamines, and in some cases sympathetic neural activity, elevates 
rapidly to peak levels within seconds of a stressful trigger or exogenous bolus of intravenous 
catecholamines. They will bind to alfa (α) and β –adrenergic receptors of all subtypes. More 
specifically for this case the endothelium and smooth muscle of the vasculature, both 
coronary and peripheral. The two receptors are G-protein coupled and can rapidly activate the 
secondary messenger pathways. (65) In a TTC rat model, Paur et al. (2012) showed that a 
high dose of intravenous EPI bolus given to rats increased the aortic blood pressure extremely 
within seconds. This in accordance with the sympathetic drive felt by patients within seconds 
of the stressful trigger. (66) Initially, this is a positive inotropic response throughout the LV 
myocardium, and peripheral vasoconstriction with rapid elevation of both systolic and 
diastolic pressures. In addition, Redfors et al. (67) claims that this hypertensive surge can 
activate a bradycardia reflex, and they recently reported that multiple catecholamines with α-
receptor activity, when injected in rats, can induce TTC-like dysfunction. This suggests that 
acute changes in systemic vascular resistance and aortic pressure may affect the myocardium, 
resulting in dysfunctional activity. (65) 
 
1-10 minutes: 
The data from respective models should be compared with caution because of the 
pharmacokinetic factors, that may account for these differences. (66, 68) Isolated 
cardiomyocyte studies show that stimulation of β-1 adrenergic- receptors results in rapid 
positive inotropy. In contrast any inotropy caused by β-2 adrenergic receptors only occurs in 




uncertain. The concept further on illustrates that β1 receptors are beginning to exert positively 
inotropic effects via PKA-mediated phosphorylation of downstream effectors. The cardio 
toxic effects may begin at this. (65) The acute effects upon the coronary vasculature remain to 
be determined, although studies have failed to show apical perfusion abnormalities during the 
acute phase. (70) 
 
0-1 Hour the ultra-acute phase: 
It is difficult to observe the initial symptoms and changes at the molecular level in a TTC 
patient. This is due to the time gap between onset and first medical contact. Therefore, many 
of the cardiovascular parameters are obtained from animal models. (65) Findings at this stage 
might be sinus tachycardia, hypertension, with pronounced pulse pressure, and ST-segment 
elevation. (71, 72) Patients report symptoms in the seconds following their stressful trigger 
consistent with an adrenaline rush or panic attack. (65) ST segment elevation is a commonly 
reported ECG finding which appears to precede the clinical apical dysfunction and 
cardiogenic shock. (65) There are also described acute left ventricular outflow obstruction 
(LVOTO) in this phase (73) which could further on exacerbate the apical dysfunction. This 
exposes the apex to higher stress compared with the basal myocardium. This high apical wall 
stress could cause apical ischemia and exceed the catecholaminergic stunning. (74) This was 
shown in an animal study where low afterload caused increased wall-tension in the apical 
myocardium because of the LV lumen obliteration. (68) The relevance of LVOTO in majority 
of TTC patients are probably limited, being prevalent in only 10 - 15% of cases. (75) A 






Figure 2: Echocardiography showing left ventricle (LV) in acute phase of Takotsubo 
cardiomyopathy (TTC) with hyperkinetic base.   
 
1-12 hours: 
The clinical presentation may occur many hours, days or weeks after the triggering event(s).  
The so called textbook TTC patient presents with chest pain, dyspnea and ST-segment 
elevation. (41, 74) Typically, during angiographic examination the coronary vessels appear 
unobstructed and the plasma catecholamines are still markedly raised. (5, 76) 
 
24-72 hours: 
During this period, a series of molecular, structural and clinical changes may offer clues to the 
underlying disease process. Nef et al. (2008) found an increased superoxide production in 
biopsy taken from the TTC patients within 12 hours after admission. These findings were 
later compared with control samples taken 21 days later, when the cardiac contractility had 
increased. Superoxide production were associated with increased gene transcription of Nrf2-
gene. (77)  
On admission, the ejection fraction (EF) was lower than the normal range (42) and remained 
depressed after 24 hours. (78) In addition, two patterns of ECG was seen in TTC patients; 




The evolution in the 24-72-hour period of widespread and deep T wave inversion and 
significant QT prolongation, compared to the admission ECG is a striking observation. (80, 
81) It is debatable that T wave inversion could help differentiate ACS and TTC. Also, the 
circulating biomarkers showed a NT-pro-BNP raise in plasma from TTC patients after 24 




In most patients, cardiac function will be improving within 3-4 days, after the onset of TTC. 
A study using serial ECG showed significantly improved LV-function between day 3 and 7, 
compared to the admission. Although the catecholamine levels were still raised. (5) This was 
confirmed in another study where 94 out of 126 patients had normalized LV function at their 
first follow up within one week. (42) Within hospital mortality is 0,5-1%, most often due to 
cardiogenic shock and multi organ failure. (83) 
 
Figure 3: A typical transthoracic echocardiography from a patient with Takotsubo 
cardiomyopathy (TTC).  
 
1.10 Different types of left ventricular dysfunction 
Different types of left ventricular dysfunction and corresponding ballooning patterns have 




basal or inverted variant, and other regional variants. (84) The most prominent type is the 
classical apical variant, which accounts for 80% of the cases. (85) The reported incidence of 
non-apical variants overall ranges from 8-40%, in different studies. (84, 86, 87) Some unusual 
cases with involvement of the right ventricle have also been reported.  
 
The heart is densely innervated by sympathetic nerves. Since these nerves follow a regional 
distribution, it has been hypothesized that the typical apical pattern of LV dysfunction results 




Figure 4: Illustration of a bull`s eye plot for a typical Takotsubo cardiomyopathy (TTC) 
patient.  
In echocardiography, the term “strain” is used to describe regional shortening, thickening 
and lengthening of the myocardium. In clinics longitudinal shortening of the myocardium 
between the apex and base is commonly used. Myocardial strain is a principle for 
quantification of left ventricular (LV) function and a new tool to quantify regional differences 
in contraction. Positive longitudinal strain means elongation (white, blue), whereas negative 
strain is shortening (red). In this representation, apical segments show dyskinesia (blue 






1.11 Stress and Takotsubo cardiomyopathy 
The connection between stress and disease has been part of folk wisdom for a long time and 
has even made its way into our language with phrases such as “scared to death” and a “broken 
heart”. Stressful events are common in everyday life, and because most people do not develop 
TTC this alone cannot explain this syndrome. Although, there are factors that can make some 
people more susceptible to stressful triggers. Risk factors such as hormonal processes (e.g. 
pheochromocytoma, stress or oestrogen depletion), endothelial dysfunction, genetic factors 
and a lifetime prevalence of depression have been suggested. Identified stressors are mostly 
emotional, such as the death of a relative or a quarrel, but can also be physical, such as the use 
of cocaine or subarachnoid haemorrhage. Despite the strong connection between acute stress 
and TTC, there is a lack of research on how patients perceive their life situation before onset 
of TTC and whether they have been subjected to long term stress. (91) 
Recent studies suggest a predisposing influence of psychiatric disorders, psychosocial stress 
and personality type D (PTD) in its pathogenesis. (92) PTD is characterized by negative 
affectivity and social inhibition. (93) Excessive or inadequate basal activity or responsiveness 
of the hypothalamus-pituitary- adrenal axis (HPAA) have been suggested as sensitive 
indicators for health and psychological conditions. (92)  
 
 
1.12 Pathophysiology of stress and catecholamine toxicity 
      Stress is a physiological response that mediates the action of a stressor on its target 
organ. The anatomic structures that mediate stress response are found in both the 
central and autonomic nervous systems. Acute emotional stressors have been shown to 
induce brain activation, increasing bioavailability of cortisol, epinephrine, and 
norepinephrine. (94) The fundamental anatomic structures involved in the stress 
response are the neocortex, limbic system, reticular formation, brainstem, and spinal 
cord. (95)  
  
When facing a threatening stimulus, and after complex neocortical and limbic integrations 
have occurred, the neural stress response occurs through activation of brainstem 
noradrenergic neurons and sympathetic adrenomedullary circuits. This results in secretion of 




of the rostral pons in the lateral floor of the fourth ventricle. The locus coeruleus function as a 
control center, and receives afferents from the hypothalamus, cingulate gyrus and amygdala, 
allowing emotional stressors to trigger noradrenergic responses. It contains the largest clusters 
of noradrenergic neurons in the brain and innervates large segments of the neuroaxis. (97) 
Activation of the locus coeruleus leads to increased NE secretion. This furthermore stimulates 
the HPAA, which consists of a complex set of three endocrine glands - the hypothalamus, the 
pituitary gland and the adrenal gland. The adrenal medulla synthesizes, store and release 
predominantly epinephrine and norepinephrine, which constitute the hormonal output of the 
neuroendocrine stress – response axis. (98) In addition to the locus coeruleus, the neural 
impulses also descend into the posterior hypothalamus, which is the pathway of sympathetic 
activation. Further on, sympathetic neural pathways descend through the cranial and sacral 
spinal cord regions and trigger the release of norepinephrine. (99) In the lateral grey column 
from T1 to L2-3 there are sympathetic preganglionic neurons that synapse with their 
postganglionic neurons. Fibers of sympathetic cardiac innervation end as sympathetic nerve 
terminals reaching the heart muscle and coronary circulation. These sympathetic nerve 
endings activate α and β postsynaptic adrenoceptors by releasing norepinephrine directly into 
the synaptic cleft. (100) The amount of catecholamine presented to the cardiac adrenergic 
receptors includes both circulating NE and EPI coupled with NE released directly from 
sympathetic nerve terminals. (101)  
The neuroendocrine stress-response axis is crucial to maintain high levels of stress arousal for 
prolonged periods. (100) The neurogenic effect is cited in many studies, and an excessive 
catecholamine-induced sympathetic stimulation of the heart, causing an acute stunning of the 
myocardium, has been suggested as a pivotal mechanism in TTC. (5) Toxicity by 
catecholamines is assumed to be higher when released to the heart by sympathetic nerves, 
than reached by blood. (102)   
Direct toxicity of endogenous catecholamines released into the heart via nerve terminals can 
cause myocardial necrosis. (103) This can result in contraction band necrosis, which 
histologically is one of the hallmarks for TTC. Contraction band necrosis is a unique form of 
myocyte injury characterized by hypercontracted sarcomeres, dense eosinophilic transverse 
bands, and an interstitial mononuclear inflammatory response and is distinct from the 





1.13 Role of oestrogen 
Oestrogen may have a protective role on the cardiovascular system of females. It reduces the 
inotropic and chronotropic response to catecholamines, and thereby alters vascular reactivity. 
(105-107) In this way, it has an important role on the vasomotor tone through the 
upregulation of endothelial nitric oxide synthase activity and there is clinical evidence of 
oestrogen attenuating catecholamine-mediated vasoconstriction. Thereby, low oestrogen 
levels in postmenopausal women increase the risk of focal left ventricular wall motion 
abnormalities. (108) Several studies have demonstrated that myocardial β – adrenoceptor 
mediated positive inotropic responses are greater in male hearts than in age – matched female 
hearts, and that these differences are mediated by reduced β-1 adrenoceptor signalling in 
women. Reduced myocardial β-1 adrenoceptor signalling in ovulating women seems to be 
protective against myocardial insults, including stress – induced catecholamine production 
and ischaemia – reperfusion injury. (109, 110)  
Ovariectomized rats with oestrogen supplement lower the negative effect of immobilization 
and stress on left ventricular systolic function, thereby protect the myocardium from 
catecholamines thorough activation of some specific pathways. (111, 112)  
 
1.14 Role of endothelial dysfunction 
Data from large cohorts have recently shown that the prevalence of cardiovascular risk factors 
such as hypertension, hypercholesterolemia and smoking in TTC patients are significant. (19, 
113, 114) Additionally, evidence show that most cases occur in patients with comorbidities 
such as neurologic and psychiatric disease. (113) These are associated with endothelial 
dysfunction and might therefore constitute a previously unrecognized predisposing factor for 
this syndrome. (115) The endothelial dysfunction can also be a part of the explanation to why 
TTC is more common in postmenopausal women. It is recognized that these women have 
both age – related and oestrogen- deficiency – related coronary vasomotor abnormalities. 
(116-118) Under physiological circumstances, oestrogen beneficially affects the coronary 
microcirculation through endothelium – dependent and –independent mechanisms, thus 





1.15 Clinical presentation 
Debut symptoms often include chest pain and/or dyspnea, which have been reported in 70% 
of patients. Additionally, ECG abnormalities with ST-segment elevation, usually in precordial 
leads and cardiac biomarkers with limited changes. Symptoms, clinical signs, and 
electrocardiographic findings in patients with TTC are suggestive of an ACS (acute coronary 
syndrome). (17) Observations of syncope, cardiogenic shock and ventricular fibrillation are 
also seen, presented in early onset. (11, 23, 27, 28, 30, 52, 119) Other symptoms seen more 
seldom are nausea, weakness and vomiting. (34, 120) When comparing genders, it is noticed 
that chest pain is reported more frequently in women, while dyspnea, syncope and no or other 
symptoms occurred with similar frequency in both sexes. (16, 29, 39) 
 
Reciprocal ST-segment changes and abnormal Q waves are often absent in TTC. 
(54) Patients with TTC and ACS share the same cardiovascular risk factors, but 
angiographic findings show that coronary atheroma and plaque rupture do not explain 
the pathophysiology of TTC. (62) To distinguish TTC from an ACS based on the ECG 
alone, is challenging and therefore access to emergency coronary angiography should 
be the procedure in all acute patients resembling ACS. (17)   
 
 
1.16 Clinical management 
Management of patients with TTC is overall supportive and conservative. Left ventricular 
depression is treated with diuretics, beta - blockers and angiotensin converting enzyme 
inhibitors. Additionally, beta - blockers may block catecholamine excess and have an 
essential role in reducing LVOTO by decreasing basal segment hypercontractility. (15) TTC 
carry a considerable morbidity and mortality risk when untreated. 
Most of TTC cases can be managed with follow up only, but the long-term prognosis is not 
entirely positive with major adverse cardiac- and cerebrovascular event rate of 9, 9% per 
patient year. (29) In the acute phase, left ventricular ejection fraction (LVEF) is often severely 
reduced, far more than for example after an acute myocardial infarction. Therefore, 
approximately 50%, of all TTC patients suffer from pulmonary congestion, and as much as 




thrombi may complicate the clinical course. Anticoagulants for primary prevention can be 
useful, also if the LVEF is relatively reduced. (121) No specific long-term pharmacological 
treatment for TTC has been established so far, only complications are treated. In a review 
form 2017 published in the “International journal of Cardiology”, Efferth et al. highlighted 
that there are no consensus recommendations for long – term management of TTC to prevent 
recurrence. (122) They referred to a multicentre retrospective study which found that chronic 
treatment with beta – blockers, ACE – inhibitors, calcium channel – blockers and aspirin did 
not improve left ventricular function. (123)     
 
1.17 Recurrence 
The five-year recurrence rate is 5-22% after initial TTC have been reported, with the second 
episode occurring 3 months to 10 years after the first. (34) Most studies have reported no 
difference in recurrence between genders, but some studies have found that the predominance 
in women is maintained. (16, 29) Hormone replacement therapy does not exclude the risk of 




Recent studies have reported life-threatening complications including left ventricular free wall 
rupture, LVOTO, thrombosis and cardiogenic shock, and the in-hospital or long-term 
outcomes are not necessarily as benign as previously reported. (126) In- hospital mortality 
was observed in 2-5% off TTC patients. (34) During hospitalization, non – life threatening 
complications occur in a high proportion (20-53%) of both female and male patients. (16, 29, 
39) 
 
1.19 Psychiatric disorders  
Anxiety and depression have been shown to increase the incidence of cardiovascular disease, 
cardiovascular events, and death. In one of the few publications, anxiety as a trait was 




increased catecholamine levels and may characterize individuals susceptible to TTC. Until 
2016 it was only two prior studies which addressed the possible association of anxiety or 
depression with TTC; they have showed conflicting results. (93) Recent retrospective studies 
have suggested that premorbid psychiatric disease could be an important predisposing risk 
factor for TTC. This finding suggests an influence of psychological factors on TTC incidence. 
(128)   
 
1.20 Personality traits and cardiovascular disease 
It is suggested that some individuals are particularly vulnerable to psychological distress, 
which can lead to the syndrome. Developing TTC relies on responses to distressing factors 
and cardiovascular reactivity to emotional stress, which is dependent on individual differences 
in personality traits. These individual differences affect the pathophysiological mechanisms 
that result in TTC. (93, 129) It is important to remember that the pathogenesis of cardiac 
disease depends not only on the number and severity of stressors, but also on unfavorable 
stress – management strategies such as negative cognitive appraisal and external locus of 
control. (130)  
Comprehensive assessments on psychological measures of stress in patients with TTC, have 
been obtained in few studies. Adverse psychological factors are suggested associated with 
TTC, which may persist well after the acute episode. (4) Characteristic thoughts, feelings and 
behavioral patterns among the patients will enhance understanding for triggers that make 
them vulnerable to TTC development. (93) One personality type that may be particularly 
relevant is PTD. (131) Some researchers like Compare et al. (2013) claim that it has been 
established as an independent predictor of acute cardiac adverse event. (93) An important 
addition in the process of clinical diagnosis and decision-making is life events, individual 
psychology (vulnerability or resilience), social factors (living conditions) and stability of 





1.21 Aim of the thesis 
The aim of the study was to assess if the personality trait of neuroticism, can increase the 
vulnerability for Takotsubo cardiomyopathy. Many studies have related takotsubo to 
psychological stress, but is the personality even more crucial? 
 
 
2 Material and method  
2.1 Management  
A literature review was conducted. We used all MeSH – terms for Takotsubo 
cardiomyopathy, personality type D, anxiety disorders, and psychological stress from 
PubMed to find appropriate publications and literature in MEDLINE, in august 2018. The 
MeSH-terms were limited with title, abstract and keyword. Since personality traits and 
neuroticism are defined concepts and not MeSH terms in PubMed, we made a separate search 
in MEDLINE with limitations title, abstract and keyword. Additionally, “exploded” the term 
personality, takotsubo cardiomyopathy, anxiety disorders, and stress psychological in 
MEDLINE and included the search results. Our search was limited to literature in the time 
period 2007-2018. Some review articles published during these years contained original 
articles released prior to 2007. Due to their relevance and important contribution to purpose of 
this study, they were included in our thesis. Study designs were limited to clinical studies, 
comparative studies, interviews, journal articles, randomized control trials, “reviews” and 
systematic reviews. 
When we read through the articles from the final search, we came across relevant content 
from other studies and thereby included these references as additional literature. 
We searched separately for “Consensus of takotsubo cardiomyopathy mayo criteria” in 
PubMed. This was performed past our literature search to find the latest update regarding 





2.2 Modified PRISMA 
 
  
Figure 5: Modified PRISMA diagram showing a summary of the literature search and 
selection of articles.  
 
3 Main results 
Our literature findings include different levels of documentation. We present the results 
accordingly; case reports and original articles. Since reviews are based on original articles, 
they are presented under the same subheading. The intention of presenting results in this order 
is to get a comprehensive overview of the literary hierarchy.  
Although the case reports are not scientifically significant, they were included in our results to 
see if the individual cases correlate with the findings in the overall literature regarding TTC.  
 
3.1 Case reports  
The reports ranges from 2008 – 2018. 2 of 22 were excluded due to irrelevance. 





3.1.1 Gender and age 
Two men were reported, remaining were women. Age range was 43-86 years, except for one 
woman whom was 23 years old. Majority of women were postmenopausal. 
 
3.1.2 Triggering events and catecholamines 
Different triggering factors were disclosed. Most of them emotional, some with a physical 
factor and few related to medical illness alone. Considering emotional cases, concerning our 
thesis, family drama (quarrel, separation, infidelity) and loss of a family member/spouse is 
worth mentioning. Still, no vulnerability for the development of TTC has been scientifically 
proven. In 5 of 20 cases, physical stress was categorized as the main reason for TTC. In the 
remaining 15 published reports, a triggering factor was thought to be emotional stress, or 
both, emotional and physical stress. One case-report described positive stress triggering TTC. 
This applied to a woman receiving a lifetime teaching award.  
Regarding explanation of pathophysiology, 9 of 20 reports highlights catecholamines as the 




Time from onset of symptoms to first medical contact was from 30 minutes to 9 days. The 
most prominent symptoms were chest pain and dyspnea, reported in 17 of the 22 patients. 
Among the remaining 5 patients, 2 patients developed TTC during anesthesia or operation, 
thereby no onset symptom could be reported. 3 patients acquired it as a complication to 
another medical emergency. Presenting symptoms here were also dyspnea and chest pain. 
Overall, patients showed ECG changes consisting of ST – segment elevation and T – wave 
inversions, with little variation in presentation. Only one patient had a normal ECG.  Further 
on, slightly elevated Troponin T or I, reduced EF 20-56% and hypokinesis or akinesia of the 
mid – or apical part of the left ventricle. 2 of the 22 patients showed an atypical pattern on 
echocardiography: 1 with dyskinesis of mid- septal, anterior and inferior wall segment and 
hyperkinetic function of basal and apical segments, and the second with mid – ventricular 




normal coronary vessels in 20 patients. 1 patient had total occlusion, and another had some 
plaque changes in the coronary vessels.  
 
3.1.4 Treatment and comorbidity 
Congestive heart failure treatment with diuretics, B-blocker, anticoagulant, ACE-inhibitors, 
were given after the diagnosis of TTC was confirmed. Additionally, relevant medications for 
comorbidity. 12 of 22 patients had hypertension, 5 of them with additional hyperlipidaemia. 6 
of 22 had several diseases and 9 of 22 had no earlier cardiovascular disease. 3 of the 22 
patients had earlier psychiatric history. In one of the reports a patient had three recurrent 
episodes, before the psychiatric history was examined. (132) 3 articles mentioned neither 
medical nor psychiatric history. 
 
3.1.5 Recurrences and deaths 
3 of 22 patients had recurrent TTC. A 43-year-old woman had 3 recurrent episodes within 4 
months. Another 51-year-old woman had 3 TTC episodes during 4 years. The last one, an 83-
year-old woman had 1 episode of recurrence, both episodes due to mild physical stress, with 4 
years apart.  
 
3.1.6 Prognosis 
Only 1 patient died. This patient was also the youngest patient, a 23-year-old woman. Her 
death was described as cardiac arrest due to life – threatening ventricular arrhythmias caused 




3.1.7 Evolution of TTC diagnostics 
Regarding criteria for diagnosis, 14 of 20 reports do not mention Mayo criteria nor other 
criteria which they have based their diagnosis upon. With this in mind, we acknowledge the 




case report from 2018, which claims that there is no single diagnostic definition for TTC. 
(133)  
We could detect a clear change in the way of viewing the diagnostic criteria of TTC. From 
2015 and onward, some reports are questioning the absence of coronary obstruction in the 
diagnosis of TTC. (64, 133, 134)  
When the presence of significant coronary artery stenosis (>50%) does not supply the 
area and extension of the myocardial dysfunction, it should not be considered an 
exclusion criterion for TTC. The coronary artery disease (CAD) is unlikely to be the 
cause of the myocardial stunning that characterizes TTC and can be considered only 
an “innocent” bystander. (64) 
 
3.2 Original articles 
We obtained original articles in two ways. Firstly, as independent publications and secondly 
as a part of reviews. Out of 28 independent original articles 14 were excluded due to 
irrelevance. Out of 37 reviews, 6 were included. We only present findings in reviews which 
were not previously acknowledged from original articles. Several of the independent articles 
reoccurred in our reviews. 
Specific themes which were encountered through all case reports were included. 
 
3.2.1 Gender and age 
We will provide some examples to show that, despite varying sample size in studies, there is a 
predominance of postmenopausal women.  
Kurisu et al. (2010) analyzed the presentation of TTC in both genders. Among their 102 
patients, 13 were male and 89 females. No significant difference in age, body weight, 
hypertension or diabetes was observed, except for height. Neither any significant difference in 
ECG was noticed. The high incidence of in-hospital onset of TTC in male patients, was cited 
to physical stress. Thereby, it is suggested that physical stress is more influential for TTC 




were women. Delmas et al. (2013) included 45 patients, with 43 females of whom 41 were 
postmenopausal. (128, 135, 136) 
 
3.2.2 Psychiatric disorders and personality traits 
An article by Scantlebury et al. (2016) is the only publication we have managed to find which 
have neuroticism linked to TTC as a part of their research issue. The focus of the study was 
on the neuroticism domain.  Regarding personality, the FFM (Five Factor Model) divides 
personality into five major domains (also called factors). These are neuroticism, extraversion, 
openness, agreeableness and conscientiousness. Neuroticism can further be divided into 
facets. The six facets of the Neuroticism scale are: Anxiety (prone to worry, fearful, 
apprehensive), Angry hostility (tendency to experience anger and related states such as 
frustration and bitterness), Depression (prone to feelings of guilt, sadness, and loneliness), 
Self – consciousness (sensitive to ridicule, prone to feelings of inferiority), Impulsiveness 
(inability to control cravings and urges), and Vulnerability (difficulty coping with stress). 
(137)   
Scantlebury et al. hypothesized that patients with TTC would have elevated levels of 
neuroticism (tendency to experience negative affect) and greater vulnerability to stress. Their 
research included 53 participant which had experienced TTC, predominantly consisting of 
women and with mean age 71,1 ± 10,3 years. (137)   
However, their results showed that TTC patients demonstrated no difference in neuroticism 
compared with the normal population. (137) They also found that TTC patients with 
emotional triggering showed no difference on the Neuroticism factor when compared with 
those without emotional triggering. There were 3 patients in the study with recurrent TTC 
which had higher Neuroticism scores, but this was not statistically significant. (137)    
Additionally, vulnerability to stress, as measured on the Vulnerability scale, was similar to the 
general population. None of the Neuroticism facets scores were statistically different from the 
normative sample. (137) These results corroborate with findings by Waldenborg et al. (2011) 
They performed a systematic screening by psychiatric interview and did not find abnormal 




These findings are in contrast to a study by Delmas et al. (2013) demonstrating that TTC 
patients have higher rates of anxiety-and depression diagnoses (128), as both diagnoses are 
correlated with elevated levels of neuroticism. Delmas et al. used MINI (mini international 
neuropsychiatric interview) for psychiatric assessment, focusing on prevalence of major 
psychiatric diseases and chronic psychological stress (CPS). Two groups were compared, 45 
cases with TTC and 50 controls with ACS. This was the first study to draw a line between the 
psychological background of TTC patients and anxio-depressive disorders (ADD). CPS was 
defined by the presence of personal, familial or social difficulties reported by the patients (e.g. 
dependent child or husband, recurrent conflicts and many deaths in relatives). Acute triggers 
seen in the study were funeral, bad memories, disappointments and separation. (128) 
In 78% of patients an acute stressful event before onset of TTC was identified vs 18% in ACS 
patients. Triggering stress was emotional for 56% of patients with TTC and 16% for ACS 
patients, which was significant. Besides the acute stress, chronic stress was found in 44% of 
TTC patients and in 18% for the ACS group. 78% of TTC patients had ADD vs 26% in the 
ACS group. Hereby, Delmas et al. confirms that major depressive disorder and generalized 
anxiety disorder are common in patients with TTC and more frequent than in those with ACS. 
This was earlier presented by Del Pace et al. (2011). They found that high – anxiety trait was 
common in patients with TTC (60%). Although, here it was no difference compared to 
STEMI patients (52%). (127)     
Compare et al. (2013) researched on whether PTD can be identified in TTC patients. Their 
study was based on 111 patients. There was 74 TTC cases: 37 patients had TTC due to an 
emotional trigger and 37 patients with TTC due a physical trigger. The control group 
consisted of 37 patients with AMI with an emotional trigger. There were predominantly 
women in all groups, with mean age 66 years old. In their research they found that patients 
who developed TTC with an emotional trigger had a higher proportion of PTD 3 months after 
the acute presentation. Subsequently, it was reported that persistence of negative 
psychological impact of the episode of TTC lasted up to 1 year. In comparison with those 
without emotional triggering. Of the 37 TTC patients with emotional triggers, 28 (76%) were 
categorized as type D compared with 13 (43%) TTC patients without emotional triggers and 




In 2014, Compare et al. did another study where they examined the wellbeing 1 year after the 
acute event of TTC. 37 TTC patient were matched with 37 AMI patients. Age range was from 
50 – 62 years, and the study consisted predominantly of women. All patients were assessed 
for health-related quality of life (HRQL) and psychological distress at baseline and 1 year 
later. They did this by investigating HRQL, and emotional burden subsequent to cardiac 
events in TTC patients. (139) HRQL was assessed by using the MacNew Heart disease Health 
– related Quality of Life self-report questionnaire, while psychological distress was assessed 
using the Psychological General Well-being index (PGWBI). (139) 
The results showed that PGWBI global, PGWBI depressed mood, PGWBI vitality and 
MacNew (measuring HRQL) global decreased significantly in both groups. Additionally, the 
percentage of patients with a moderate or severe rating of psychological distress 1 year after 
the cardiac event, was significantly higher in the TTC (70,2%) group. This compared with 
AMI (37,8%), independent of trigger event topology (emotional vs. physical). Findings were 
shown to be independent of gender. (139) 
In 2015, the international Takotsubo registry revealed that more than half of patients with 
TTC had preceding neurologic or psychiatric disorders. (29) Among the psychiatric disorders 
related to TTC, anxiety is one of the most frequent. (140) Similar to Del Pace et al. research 
in 2011, Lazzeroni et al. did a recent study (2018), investigating if there was a link between 
TTC and anxiety. The study was retrospective and anxiety disorders were evaluated from 
medical records, pre – existing psychiatric diagnosis and/ or chronic use of benzodiazepines. 
56 TTC patients were included in the study, mean age was 70 years, and women were 
overrepresented. Patients were divided into TTC with exclusively emotional trigger, TTC 
with a physical trigger and TTC with an undetermined trigger. (141) 
Their results showed that 31 of the 56 TTC patients had a pre – existing anxiety disorder. 
Additionally, they found that exclusively emotional stressful events were more common in 
TTC patients with pre – existing anxiety disorder. In contrast, undetermined stressful events 
were more common for TTC patients without a history of anxiety disorders. (141) 
In 2016 Goh et al. also explored the themes anxiety and depression in TTC patients. Their 
psychiatric assessment was through HADS (hospital anxiety and depression scale), which is 




Depression was not associated with TTC and neither conditions were seen frequent in ACS 
patients. Summarizing with higher levels of anxiety are associated with particularly 
emotionally triggered TTC. (127, 142)  
Another study that supports the assertions that anxiety is a precipitating factor for TTC, was a 
study by Smeijers et al. in 2016. They examined whether patients with TTC had higher levels 
of psychological distress (depressive symptoms, perceived stress, general anxiety), illness – 
related anxiety and distinct personality factors. This compared with healthy controls and 
patients with chronic heart failure. TTC patients were identified by reviewing electronic 
medical records over a 5-year period (2009 - 2014). The study consisted of 18 TTC patients, 
19 healthy controls and 19 patients with chronic heart failure. Patients with TTC in response 
to surgery or acute injury were not included. The distribution of women vs. men were 
relatively similar in all 3 groups, with age ranging from approximately 50 – 80 years. 
Psychological measures were obtained 23 ± 18 months past the acute event of TTC. NEO – 
FFI (NEO Five – factory Inventory) were used to assess personality factors, depressive 
symptoms were assessed using Patient Health Questionnaire (PHQ-9) and the DS – 14 for 
PTD. (4) 
Results showed that TTC patients did not display significantly elevated levels of perceived 
stress or general anxiety. However, measurement of depressive symptoms and illness – 
related anxiety were significantly higher in TTC patients compared with healthy controls. 
Regarding PTD, the subscales negative affectivity and social inhibition did not differ between 
TTC patients and the control groups. (4)  
 
3.2.3 Impact of long-term stress 
As opposed to the studies mentioned above, focusing on acute events prior to TTC, we now 
present the impact of long-term stress. Wallström et al. (2016) did a qualitative study 
presenting personal experiences from the informants. Data were collected through narrative 
interviews with aim to analyze impact of prolonged stress. Their findings based on low 
intensity stress experienced over a long time period triggering TTC, rather than an acute 
stressful event. Situations could be addressed back years, even decades. Another dominating 




seem at peace with their situation in life or how it had become. Main concerning themes were 
everlasting responsibilities, recurring injustice and perpetual uncertainty. Conclusively their 
findings indicate that prolonged stressful circumstances make individuals vulnerable. This 
vulnerability further on cause increased risk for onset of TTC. They claim that this study 
might be an answer to why a minority of people develop TTC, although a lot more are 
exposed to stress during their life. (91) 
Further on in 2017, Rosman et al. explored the cumulative impact of stressful life events on 
the development of TTC. They sought to examine the association between type, timing and 
number of stressful life events. This study was based exclusively on women. Included in the 
study were 45 TTC patients, 32 myocardial infarction (MI) patients and 30 healthy controls 
(HC). Medical history, including history of anxiety and depression was obtained from 
medical records. Results showed that onset of TTC was associated with exposure to multiple 
stressful life events during 6 months prior to index hospitalization, but not associated with 
exposure to an acute, recent event. The mean total number of stressful life events differed 
significantly between groups, with TTC women reporting a greater number of prior stressful 
life events than the control groups. A history of anxiety disorders was also more prevalent 
among TTC cases than control groups. (143)    
 
3.2.4 Positive emotional stress 
A publication by Ghadri et al. (2016), is the only original article in our research which 
explored the role of positive emotional stress. Their results show that out of 485 TTC patients, 
4.1% experienced positive emotional stress, while the remaining 95.9% experienced negative 
emotional stress. Women were overrepresented in both groups. Of note, the majority of 
patients was unemployed or retired at the onset time. Positive factors were birthday party, 
wedding, family party or winning jackpots on casino. This study may indicate that both happy 
and sad life events, may share common pathway in CNS. Regardless of the triggering stress 






3.2.5 Pathophysiology of stress 
Due to lack of relevant literature, results from one study is presented for this topic. 
Smeijers et al. (2015) presented the hormonal responses to different kind of stress in 18 TTC 
patients. Stress was categorized as: physical exercise, mental challenging task and emotional 
recall of anger, irritability and distress. They were compared to 19 patients with heart failure 
and 19 healthy controls. Participants rated mood adjectives on a 7 – point Likert scale.  
Hormones analyzed were dopamine (DA), NE, EPI, adrenocorticotropic hormone (ACTH) 
and cortisol, and were compared to baseline levels. Levels of DA and NE during mental stress 
and exercise were significantly higher in patients with TTC compared with healthy controls. 
No differences were observed for EPI levels during mental stress. Elevated levels of cortisol 
and ACTH were also seen, but not differing in groups. Responses of the HPAA and 
hemodynamic reactivity were not increased in TTC patients. Another point worth mentioning 
is that emotional response to mental stress were not exaggerated in TTC but showed a blunted 
arousal response compared with healthy controls. Their conclusion provided preliminary 
evidence of hyperreactivity of the sympathetic nervous system. This in response to mental 
stress and exercise, but no emotional hyperreactivity in patients with TTC were observed. 
Their findings also corresponded with literature on acutely elevated catecholamine levels 
during TTC admission. The lower stress-induced arousal response in TTC versus controls was 
unanticipated considering studies exploring psychological traits related to TTC. (92) 
 
We now continue to present original articles obtained from reviews.  
3.2.6 Psychiatric disorders and personality traits 
A patient cohort that may be predisposed to development of TTC is the population with 
psychiatric disorders. (144) Summers et al. (2010) reports a higher prevalence of mood 
disorders and anxiety in TTC patients. They found that 68% of patients had either anxiety or 
depression, and prevalence of those two diseases were more frequent than in those with 
myocardial infarction. Furthermore, in retrospective analyses, these patients were more likely 
to be divorced, to be living alone, and to have a family history of affective disorders. (145) 
Not only may psychiatric disorders predispose to TTC, but an exacerbation of psychiatric 




Redfors et al. (2013) reports in their review that acute severe emotional stress can trigger TTC 
and thereby is given the name stress induced cardiomyopathy / broken heart syndrome. They 
sum up studies which have found that anxiety and chronic stress both are associated with 
higher odds for developing TTC. Further on they believe that TTC may occur acutely in 
biologically predisposed individuals, this in response to an acute stressor. This predisposition 
is thought to be caused by chronic stress or impaired well-being. (146) 
Lacey et al. assessed psychosocial risk factors such as depression, anxiety, trauma, 
extraversion, and neuroticism in different cohorts. Two groups had experienced an 
earthquake: a TTC groups who experienced initial symptoms immediately after the 
earthquake, and healthy controls experiencing the earthquake. The last groups of patients had 
TTC but were not affected by the earthquake. Psychiatric symptoms and personality traits 
showed no difference between groups. However, 59% of patients with earthquake – triggered 
TTC and 42% with sporadic TTC had experienced trauma in the past. They also found that 
both TTC groups had a more pronounced expression of neuroticism. (147)  
 
3.2.7 Pathophysiology of stress 
Balkin et al. (2011) report in their summary a multifactorial pathogenesis in patients who 
develop TTC. A pattern is described starting with; 1) extreme unrelenting emotional event 
which unleashes a catecholamine surge as a result of positive feedback loop in the 
psychologic stress system 2) extra ordinarily high levels of catecholamines disrupt cardiac 
function through direct cardiomyocyte toxicity, 3) excessive coronary artery adrenergic 
stimulate and the postmenopausal oestrogen-deficient women is particularly susceptible to the 
actions of the catecholamines surge. (148) 
Evidence supporting this mechanism were provided by Wittstein et al. (2005) in their research 
on catecholamine levels after sudden emotional stress, comparing TTC patients with AMI 
patients. (31)   
Results showed that TTC patients demonstrated both higher plasma EPI levels as well as NE 
levels in comparison to the AMI group, after sudden emotional stress. Initial plasma levels 
were several times those of patients with myocardial infarction and remained markedly 




In clinical states of catecholamine excess, contraction-band necrosis has been described. This 
form of necrosis has also been observed post mortem in people who died under terrifying 
circumstances, such as fatal asthma (149) , and violent assault (150), suggesting that 
catecholamines may be an important link between emotional stress and cardiac injury. 
Dysregulation of the HPAA can be influenced by chronic stress and contribute to the 
development of cardiovascular disorders. (130) It has been formerly shown that vagal tone 
decreases while the response to adrenal medullary hormone increases, when patients with 
depression experiences stressful events. (144) Additionally, some patients with depression 
have shown very high amounts of NE release, which can lead to higher levels of circulating 
catecholamines. (151) Depressed patients showed an exaggerated NE response to emotional 
stress. (152) Some reports claim decreased catecholamine reuptake due to impairment of the 
NE- transporter in some patients with panic disorder and anxiety. This may lead to prolonged 
stress response. (153) 
Other studies have sought to examine the role of cortisol in patients with TTC. In some 
studies, it has previously been suspected that the cortisol level in TTC patients would differ 
from healthy controls. Kastaun et al. reports in their own investigation that no difference has 
been detected. (154) This applies to serum concentrations of evening cortisol, basal urinary 
concentrations of cortisol and basal morning salivary cortisol. (155, 156) The result was 
supported by Collste et al, which found no difference in morning salivary cortisol levels 
between patients with TTC and healthy controls. (155) On the other hand, cortisol levels 
during mental stress is unclear. Collste et al. and Kastaun et al. both found that the cortisol 
stress response (CSR) was reduced in TTC patients compared to healthy controls. 
Nevertheless, both emphasize that this result is inconclusive due to unclear protocol and small 
sample sizes. (154, 155) Despite a blunted cortisol response, patients with TTC felt more 








One of the challenges with literature regarding TTC and psychosocial risk factors is the 
paucity of data. Additionally, large cohorts and studies for extended periods are missing. 
Small sample sizes apply to most studies and may be the most significant limitation in terms 
of findings within this field.  
Anxiety and depression are traits observed in TTC patients. Studies report a link between 
anxiety and TTC (127), while the correlation between depression and TTC is uncertain. 
Although, depressed people show an exaggerated response to emotional stress. (151) It is still 
difficult to determine whether emotional stress results in anxiety, anxiety contributes to TTC 
or TTC itself arises anxiety. (142) 
It is important to recognize the difference between anxiety as a “trait” versus anxiety 
as a “state”. In the field of personality assessment, traits are conceptualized as stable 
personality dispositions that are relatively invariant across situations, and that have a 
significant biological substrate. Conversely, states are transient emotional reactions 
that are highly sensitive to the situational context. (137) 
In the study by Del Pace and colleagues (2011), patients were studied during the index 
hospitalization, and in the study by Compare and colleagues (2014), evaluation was done at 3 
months following TTC. In these cases, findings may be reflective of ongoing life stressors 
that were associated with the index event (a “state”) rather than an intrinsic personality trait. 
(127, 137, 139) 
Neuroticism and PTD are both characterized by negative emotional states. So far, no 
connection is observed between PTD, neuroticism and TTC. Enough research has not been 
done.   
TTC is perceived as a female disease. This with good grounds, as most patients are 
postmenopausal women. One theory regarding postmenopausal women and their vulnerability 
for TTC is changes of oestrogen levels. In sufficient levels, oestrogen has a cardioprotective 
role. While low levels of oestrogen may make the heart more vulnerable for the 





In regard to criteria for TTC diagnosis, there is currently a lack of international unity. An 
expert consensus statement was presented by Ghadri et al. in 2018. (157) This paper 
addresses the importance of universal agreement regarding guidelines for TTC. Diagnostic 
criteria have been presented several times earlier. The first criteria were proposed by Abe et 
al. in 2003. (20) A year later (2004), a dedicated group of cardiologists from the Mayo Clinic 
proposed new criteria’s. (41) Since then other research groups have come up with several 
proposals, with variation according to which country the criteria have been proposed by. 
(157) The consensus paper from 2018 submitted new international diagnostic criteria, the 
International Takotsubo Diagnostic Criteria (InterTAK Diagnostic Criteria). As some of the 
formerly exclusion criterions are a part of the new guidelines, the paper presents a 
justification for why they should be included. According to InterTAK Diagnostic criteria, 
pheochromocytoma is not an exclusion for TTC diagnosis, since it may serve as a trigger. 
(157) In addition, TTC may coexist with ACS (158), and it has been reported that ACS itself 
can trigger TTC. (159-162) One should suspect coexistence with TTC and obstructive 
coronary disease when the area of wall motion abnormality is not supplied by the obstructed 
vessel. (163) Due to this, significant coronary artery disease is not a contradiction in TTC. 
(157)    
“While the evidence supports a link between acute psychological triggers and cardiovascular 
risk, there is no convincing evidence for specific prevention at an individual level.” (164) 
 
Limitations 
We have highlighted a specific aspect of TTC, and thereby relevant literature are limited. 
Additionally, material obtained was based on small populations, which may influence our 
results. It is thereby difficult to claim that our results are significant. In addition, many articles 
which was appropriate for this thesis, were not accessible through University of Tromsø`s 








To analyze a subject with limited relevant literature is also a strength, because it raises interest 
towards a new aspect. 
 
Implication 
So far, our study may not contribute to any change in clinical practice. Nevertheless, it can 
contribute to raise awareness regarding TTC and neuroticism at this point. Ultimately, and 
most importantly, this issue needs more research to ensure a better understanding of the risk 
factors for TTC. 
 
5 Conclusion 
Throughout life, people will experience different stressors, with various degree of burden. 
Response to distressing factors build upon the way individuals process and react to it, along 
with cardiovascular vulnerability. This in turn depends on personality traits, vulnerability and 
resilience. Our results have shown an increased prevalence of psychiatric disorders in TTC, 
and anxiety has proven to be a prominent feature. However, there are no unambiguously 
results regarding the correlation between TTC, depression, PTD and neuroticism.  
Most studies identify stressful events immediately preceding the presentation of symptoms. 
However, some results indicate that exposure to repeated stressful events, rather than 
temporal proximity, may have a more decisive role in onset of TTC.  
In most studies TTC patients are compared with AMI patients, because they have similar 
clinical presentations and are expected to have a high sympathetic tone. 
Throughout it is evident that more postmenopausal women are reported compared to men and 
younger adults. Majority have an emotional stressor combined with physical or isolated 





Regarding aim of the study, evidence is inconclusive at this point. Few articles on neuroticism 
as a precursor to TTC are published, and sufficient knowledge is not available. Several and 
larger studies are still needed. Therefore, we have attempted to draw attention towards this 
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